![]() |
市場調査レポート
商品コード
1629041
インジェスチブルセンサーの市場規模、シェア、成長分析、タイプ別、最終用途産業別、地域別 - 産業予測、2025年~2032年Ingestible Sensor Market Size, Share, Growth Analysis, By Type (Imaging Capsules, Temperature Sensing Capsules), By End-use Industry (Healthcare/Medical, Sports & Fitness), By Region - Industry Forecast 2025-2032 |
||||||
|
インジェスチブルセンサーの市場規模、シェア、成長分析、タイプ別、最終用途産業別、地域別 - 産業予測、2025年~2032年 |
出版日: 2025年01月05日
発行: SkyQuest
ページ情報: 英文 297 Pages
納期: 3~5営業日
|
世界のインジェスチブルセンサーの市場規模は、2023年に8億2,500万米ドルとなり、2024年の9億1,492万米ドルから、2032年までには20億9,333万米ドルに成長し、予測期間(2025年~2032年)のCAGRは10.9%で成長する見通しです。
デジタル医療分野は、心拍数、脈拍、血圧などの重要な身体機能をモニターし、急性医療問題の継続的な検出を提供する、摂取可能なセンサーの出現によって画期的な進歩を遂げています。これらの非侵襲的デバイスは、スマートフォンへのデータ転送を容易にするアプリケーションに接続し、患者が健康状態を効果的に分析できるようにします。看護師や医師のような医療専門家は、患者のモニタリングと診断を強化するために摂取可能なセンサーを活用し、それによって的を絞った治療計画を立てます。COVID-19の大流行は、患者の遠隔診断の重要性を浮き彫りにし、こうした革新的なセンサーの需要を押し上げています。侵襲的な処置とは異なり、体内の健康状態を包括的に把握しながら患者の安全を確保できるため、パンデミックがもたらす課題の中で医療技術の重要な進歩を示しています。
Global Ingestible Sensor Market size was valued at USD 825.0 million in 2023 and is poised to grow from USD 914.92 million in 2024 to USD 2093.33 million by 2032, growing at a CAGR of 10.9% during the forecast period (2025-2032).
The digital medical sector is witnessing a breakthrough with the emergence of ingestible sensors, which monitor vital bodily functions such as heart rate, pulse, and blood pressure, offering continuous detection of acute medical issues. These non-invasive devices connect to applications that facilitate easy data transfer to smartphones, enabling patients to analyze their health outcomes effectively. Medical professionals like nurses and doctors leverage ingestible sensors for enhanced patient monitoring and diagnosis, thereby developing targeted treatment plans. The COVID-19 pandemic has underscored the importance of remote patient diagnostics, driving demand for these innovative sensors. Unlike invasive procedures, they ensure patient safety while providing a comprehensive view of internal health, marking a significant advancement in medical technology amidst the challenges posed by the pandemic.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Ingestible Sensor market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Ingestible Sensor Market Segmental Analysis
Global Ingestible Sensor Market is segmented by Type, End-use Industry and region. Based on Type, the market is segmented into Imaging Capsules, Temperature Sensing Capsules, Medication Monitoring Pills and Others. Based on End-use Industry, the market is segmented into Healthcare/Medical, Sports & Fitness and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Ingestible Sensor Market
The global ingestible sensor market is experiencing significant growth driven by rapid advancements in health technologies and the increasing adoption of medical applications by healthcare professionals. The ongoing pressures from the COVID-19 pandemic have further accelerated this growth, as overwhelmed healthcare systems face challenges in accommodating a rising number of patients. To mitigate this issue, healthcare providers are increasingly relying on ingestible sensors for remote monitoring and treatment options. Additionally, in developing countries where quality health insurance is often unaffordable, ingestible sensors present a viable alternative for those seeking effective yet cost-efficient medical solutions. This combination of technological progress and evolving healthcare demands is propelling the ingestible sensor market forward.
Restraints in the Global Ingestible Sensor Market
The global ingestible sensor market faces significant constraints primarily due to the high costs associated with these sensors. Their expense, particularly in the context of swallowable medications, limits accessibility primarily to affluent individuals and healthcare institutions. This financial barrier poses a substantial challenge for broader adoption and utilization of ingestible sensors, hindering market growth. Consequently, the limited affordability restricts the potential consumer base, which in turn impacts the overall expansion of the ingestible sensor market on a global scale. Without addressing these cost issues, the market's growth may remain stifled, preventing it from reaching its full potential.
Market Trends of the Global Ingestible Sensor Market
The Global Ingestible Sensor market is witnessing a notable upward trend, particularly fueled by advancements in the medical and healthcare sectors. With capsule endoscopes being established for roughly two decades, their integration into patient monitoring, controlled drug delivery, and diagnostic procedures signifies a growing acceptance of ingestible technology. By 2021, the market's expansion is driven by the increased demand for improved medication adherence solutions and the necessity for real-time health tracking, allowing healthcare providers to receive timely updates on drug interactions and patient compliance. This convergence of technology and healthcare is poised to enhance patient outcomes and redefine medical diagnostics.